Miscellaneous Quiz / Thera2-ThromboembolicDrugs

Random Miscellaneous Quiz

Can you name the Thera2-AnticoagulantDrugs?

Quiz not verified by Sporcle

Forced Order
Score 0/69 Timer 20:00
Lepirudin, Argatroban, and Dabigatran all work by directly inhibiting _______.
UFH inactivates factors: ___ (most), X, IX, XI, and XII.
UFH treatment dosing is: ___units/kg bolus followed by 18 units/kg/hour.
T or F: Fondaparinux administration might produce injection site reactions.
Brand Name UFH
Brand Name Fondaparinux
T or F: If a patient experiences HIT II on UFH therapy, stop treatment immediately.
T or F: Enoxaparin inhibits factor II more than factor X.
Fondaparinux monitoring may include: ___
Warfarin also interferes with endogenous anticoagulant proteins ___ & S.
Enoxaparin's starting TREATMENT dose is: ___mg/kg SQ BID or 1.5mg/kg daily.
T or F: UFH treatment doses are given as a continuous IV.
Monitoring parameters of Warfarin are: prothrombin time and ____
Warfarin works by interfering with _______ synthesis of vitamin K dependent clotting factors.
Side effects of Dabigatran are bleeding and _________.
UFH toxic monitoring includes: bleeding complications and ___ every other day x 2 weeks or until stopped
Brand Name Enoxaparin
The goal aPTT for UFH therapy is ___-___. (enter as # - #)
Warfarin dosing is: initiate __mg PO after UFH or LMWH initiated.
T or F: 2C9 & 3A4 inhibitors and decreased vitamin K DECREASE the effect of warfarin.
UFH works by binding to ______, converting it from a slow inhibitor to a rapid inhibitor of thrombin.
T or F: Direct thrombin inhibitors have a reversal agent.
Enoxaparin works by enhancing the activity of _____.
UFH target patients include all except: (a) immobile (b) post-op (c) trauma (d) spinal cord injuries (e) all of the above are target patients.
When using Enoxaparin, anti-Xa should be monitored if the patient is _____, pregnant, or has renal insufficiency.
T or F: Enoxaparin requires dose adjustment in renal impairment.
T or F: Fondaparinux treatment dosing is weight based.
Toxic monitoring parameters of Enoxaparin include: ____ and signs of bleeding.
T or F: Phytonadione (Vitamin K analog) is an antidote to warfarin.
Lepirudin's dose is given as a ______ infusion.
UFH therapeutic monitoring for treatment doses includes: ___
T or F: Cholestyramine interferes with warfarin absorption.
T or F: Patient education regarding enoxaparin should include teaching the patient how to inject the drug.
Side effects of UFH therapy include: bleeding, _________, HIT I, HIT II, and osteopenia.
Possible side effects of Warfarin include: bleeding, ____ necrosis, and purple toe syndrome.
Brand Name Lepirudin
Normal prothrombin time is __-__ seconds (enter as # - #)
Warfarin inhibits vitamin K _______ reductase.
Warfarin's R-isomer is metabolized by CYP450 3A4 & ___
Brand Name Warfarin
Argatroban is indicated for HIT or ____
Warfarin's S-isomer is metabolized by CYP450 ___.
Normal INR is __-__ (enter as # - #)
Treatment dose of Fondaparinux for a patient < 50kg is: ___mg
Heparin's antidote
Enoxaparin's starting PROPHYLACTIC dose is: ___mg SQ BID or 40mg SQ daily.
Fondaparinux works through anti-___a activity only.
Fondaparinux is used for prophylaxis & treatment of DVT/PE, ACS, and ___ (not FDA approved)
T or F: Warfarin is approved for prophylaxis & treatment of DVT/PE, acute MI, prosthetic heart valves, atrial fibrillation, and inherited clotting disorders.
Lepirudin is indicated for ____ treatment in HIT patients.
Treatment dose of Fondaparinux for a patient weighing 50-100kg is: ___mg
Fondaparinux prophylactic dosing is: ___mg SQ every 24 hours
Enoxaparin is indicated for the treatment & prophylaxis of DVT/PE and acute MI/_____ angina.
T or F: Argatroban is given as a continuous IV infusion and requires dose adjustment for hepatic impairment.
Warfarin interferes with clotting factors: ___, ___, ___, and ___. (enter in order of longest to shortest time; separate answers by commas))
UFH prophylactic dosing is: _____ units SQ every 8-12 hours.
Argatroban might cause a false elevation in INR of __-__ points. (enter as # - #)
T or F: UFH therapeutic uses include: prophylaxis & treatment of DVT/PE, acute coronary syndromes, and atrial fibrillation.
Phytonadione Brand Name
Dabigatran dosing is: ___mg PO BID.
Treatment dose of Fondaparinux for a patient weighing > 100kg is: ___mg
Brand Name Dabigatran
T or F: If a patient experiences HIT I on UFH therapy, stop the treatment stat.
Dabigatran dosing in renal impairment (CrCl 15-30mL/min) is ___mg PO BID
T or F: Fondaparinux has more thrombocytopenia than LMWH.
Some side effects of Enoxaparin include: bleeding, thrombocytopenia, and ____ at the injection site.
T or F: Possible drug interactions with Dabigatran include p-glycoprotein inhibitors or inducers, e.g. PPIs and antacids.
Dabigatran is indicated for: ____ ____
When on Lepirudin, ____ should be monitored every 4 hours until stable.

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Join for Free
Log In

You Might Also Like...

Show Comments


Created Mar 7, 2011ReportNominate

Top Quizzes Today

Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.

Report this User

Report this user for behavior that violates our Community Guidelines.